Company research / VNOV
VitaNova Life Sciences Corp (VNOV)
- Sector Wholesale Trade
- Incorporated NV
- Fiscal year ends Apr 30
For the year ended 2026-04-30, VitaNova Life Sciences Corp reported revenue of $3.03M. Revenue grew 13.7% from the prior annual period.
Key ratios (year ended 2026-04-30)
30.1%
Gross margin
0.1%
Operating margin
-1.2%
Net margin
-1.8%
Return on year-end equity
13.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.